GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medinice SA (WAR:ICE) » Definitions » Short Interest

Medinice (WAR:ICE) Short Interest


View and export this data going back to 2018. Start your Free Trial

What is Medinice Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Medinice's Short Interest

For the Medical Devices subindustry, Medinice's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinice's Short Interest Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medinice's Short Interest distribution charts can be found below:

* The bar in red indicates where Medinice's Short Interest falls into.



Medinice (WAR:ICE) Business Description

Traded in Other Exchanges
N/A
Address
ul. Karola Olszewskiego 6, Kielce, POL, 25-663
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.